Hans-christian C. Kolberg - Publications

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 21, 2026

Recommendations for Improving the Modeling of Wintering Waterbird Population Sizes and Trends.

Journal: Ecology and evolution

Published: December 05, 2025

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry.

Journal: NPJ breast cancer

Published: November 29, 2025

Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial.

Journal: Breast cancer research and treatment

Published: October 24, 2025

Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E.

Journal: BMC cancer

Published: June 18, 2025

Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 10, 2025

Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 05, 2025

TARGIT-IORT in early breast cancer-real world evidence for a risk-adapted approach.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: May 31, 2025

Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 16, 2025

Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.

Journal: The British journal of surgery

Published: April 30, 2025

Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 10, 2025

Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.

Journal: Breast cancer research and treatment

Published: January 10, 2025